Study to Determine Effective Dosing of Fondaparinux in Obese Persons

Withdrawn before enrolling · Phase 1

Conditions studied: Morbid Obesity

In brief

This is a prospective open-label study comparing two dosing regimens of fondaparinux, which is used to prevent deep vein thrombosis, in morbidly obese volunteers.

Key facts

Study ID
NCT00346879
Run by
Indiana University
People needed
0
Starts
2006-08-01
Expected to finish
2009-01-01
Last updated by the study team
2016-02-23

Who can join

Age: 19 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.